Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Plerus** is an oral herbal syrup marketed by Pharma Pharmaceutical Industries for symptomatic respiratory use. The registered product is described as containing *Pelargonium sidoides*, thyme, and ginger extracts. It is intended to support relief of cough, mucus production, and symptoms associated with upper respiratory tract inflammation, including acute bronchitis. Its activity is attributed to the combined traditional phytotherapeutic effects of the botanical extracts, including expectorant, anti-inflammatory, antimicrobial, antiviral, and immunomodulatory effects; no single molecular target or formally established molecular mechanism has been specified.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Plerus.